ATHANASIOS KARAGIANNIS
Profile Summary
Profile Picture:
Gender: Male
Speciality: Oncology
Position : Consultant
Nationality : Greece
Have you worked in Saudi Arabia?: No
Duration in Saudi:
Current Location: Greece
Certificates Earned: --M.D. Degree University of Turin – Italy, Faculty of Medicine --Certificate of medical specialization in Medical Oncology, awarded by the Greek Prefectures following Specialist Certificate Exam (Greek Board of Medical Oncology) --License to practice medicine, issued by the Health Department of the Local Prefecture in Greece --License to practice medicine by the Italian ministry of health following the Successfully competition of the “State examination for the qualification to practice the profession of medicine” (Esame di Stato)
Scientific Achievements: Research Experience RESEARCH: Research grant by Hellenic Society of Medical Oncology for 1 year 2010 Hellenic society of medical oncology annual grant for research. Study on kallikrein 6 & 7 gene expression (KLK6 & KLK7). RESCERCH 2010 - 2012 “Study of the Effect of chemotherapeutical drugs on kallikrein 6 & 7 gene expression (KLK6 & KLK7) on MCF-7 breast cancer cells”. Award : 2nd Best Poster for : Study of the Effect of chemotherapeutical drugs on kallikrein 6 & 7 gene expression (KLK6 & KLK7) on MCF-7 breast cancer cells. 9thPanhellenic Congress of Tumor Markers and targeted therapy. RESCERCH 2010 – 2014 Serum Neuregulin 1 (NRG1), Betacellulin (BTC), Epiregulin (EPR), Heparin binding epidermal growth factor like growth factor (HB-EGF) and TGF-a, as Biomarkers in advanced breast cancer. PUBLICATIONS IN INTERNATIONAL JOURNALS HYPERLINK http://www.ncbi.nlm.nih.gov/pubmed/19775466 Salvage therapy of pretreated advanced breast cancer with bevacizumab and paclitaxel every two weeks: a retrospective case review study. Ardavanis A, Doufexis D, Kountourakis P, Malliou S, Karagiannis A, Kardara E, Sykoutri D, Charalampia M, Rigatos G.BMC Cancer. 2009 Sep 23;9:338. PMID: 19775466 [PubMed - indexed for MEDLINE] HYPERLINK http://www.ncbi.nlm.nih.gov/pubmed/20044638 Biweekly gemcitabine (GEM) in combination with erlotinib (ERL): an active and convenient regimen for advanced pancreatic cancer. Ardavanis A, Kountourakis P, Karagiannis A, Doufexis D, Tzovaras AA, Rigatos G. Anticancer Res. 2009 Dec;29(12):5211-7. PMID: 20044638 [PubMed - indexed for MEDLINE] HYPERLINK http://www.ncbi.nlm.nih.gov/pubmed/20683040 Bevacizumab combined with two-weekly paclitaxel as first-line therapy for metastatic breast cancer. Kountourakis P, Doufexis D, Maliou S, Karagiannis A, Kardara E, Margari C, Sykoutri D, Tzovaras A, Ardavanis A. Anticancer Res. 2010 Jul;30(7):2969-71. PMID: 20683040 [PubMed - indexed for MEDLINE] HYPERLINK http://www.ncbi.nlm.nih.gov/pubmed/21498734 Effective Panitumumab treatment in patients with heavily pre-treated metastatic colorectal cancer: a case series. Tzovaras AA, Karagiannis A, Margari C, Barla G, Ardavanis A. Anticancer Res. 2011 Mar;31(3):1033-7. PMID: 21498734 [PubMed] ΑΒSTRACTS PUBLICATIONS IN SUPPLEMENTS of INTERNATIONAL JOURNALS -Successful Treatment With Lapatinib and Capecitabine of a Pre-treated Breast Cancer Patient With Lymph Nodes and Liver Metastases A KARAGIANNIS, AA TZOVARAS, D DOUFEXIS, A NTOKOU, A ARDAVANIS St. Savvas Anticancer Hospital, Athens, Greece The oncologist International Patient Case Forum Abstracts August 2010 -Near Complete Response of Skin Disease in a Patient With Metastatic Breast Cancer Treated With Lapatinib and Capecitabine A KARAGIANNIS, AA TZOVARAS, D DOUFEXIS, A NTOKOU, A ARDAVANIS St. Savvas Anticancer Hospital, Athens, Greece The oncologist International Patient Case Forum Abstracts August 2010. -Significant Long-Term Response and Survival in a Breast Cancer Patient With Extensive Central Nervous System Involvement and Extensive Bone Disease Treated With Lapatinib and Capecitabine A KARAGIANNIS, AA TZOVARAS, D DOUFEXIS, A NTOKOU, A ARDAVANIS St. Savvas Anticancer Hospital, Athens, Greece The oncologist International Patient Case Forum Abstracts August 2010 -Salvage therapy of pretreated advanced colorectal cancer (ACRC) with biweekly cetuximab (CTX), oxaliplatin (OX) and capecitabine (CAP). Preliminary results. Annals of oncology: Supplement 6: 12 World congress on Gastrointestinal cancer Tzovaras A, Karagiannis A, Ntokou A,Doufexis D, Margari C,Barla G, Tsoukalas G, Stavrinidis E, Ardavanis A. -Bevacizumab (bev) and Paclitaxel (pac) every two weeks as first line treatment for advanced breast cancer. Preliminary results of case series. Proccedings of the 2008 San Antonio Breast Cancer Symposium. Ardavanis A., Doufexis D., Kountourakis P., Malliou S., Karagiannis A., Kardara E., Sykoutri D., Kandylis C., Rigatos G. -HAEMA. The Journal of the Hellenic Society of Haematology, Flashes in haematopathology - case 14 K. Chantziara, Α. Karagiannis, V. Vesleme, M. Mantzourani, J. Griniatsos, A. Androulaki, J. Meletis. Haema 2005; 8(3):528-529 -HAEMA. The Journal of the Hellenic Society of Haematology, - Flashes in clinical haematology case 31 A. Antoniadis, K. Chantziara, Α. Karagiannis, P. Chatzinikolaou, M. Mantzourani, J. Meletis Haema 2004; 7(3):389-390 PUBLICATIONS IN NATIONAL JOURNALS Review article : Autoinflammatory disorders N.G. Evangelatos, P. Konstantopoulou, L. Pantazi, A. Karagiannis, G. Vaiopoulos 1st Dept of Internal Medicine, University of Athens, Laikon Gen. Hospital, Athens, Greece Hellenic Rheumatology 2007; 18(2):130-137 PRESENTATIONS IN INTERNATIONAL CONGRESSES: Bevacizumab (bev) and Paclitaxel (pac) every two weeks as first line treatment for advanced breast cancer. Ardavanis A., Doufexis D., Kountourakis P., Malliou S., Karagiannis A., Kardara E., Sykoutri D., Kandylis C., Rigatos G. Preliminary results of case series. Poster in the 2008 San Antonio Breast Cancer Symposium. Biweekly Gemcitabine (GEM) with erlotinib (ERL): an active and convenient regimen for advanced pancreatic cancer. Ardavanis A., Kountourakis P., Karagiannis A., Doufexis D., Tzovaras A., Rigatos G. ICACT 20th International Congress On Anti – Cancer Treatment, Paris, France 2009. Skin metastasis as an early sign of stomach cancer. Tzovaras A, Karagiannis A, Margari C, Ardavanis A. 21st Ιnternational Congress on anticancer treatment 1st-5th February 2010 Paris, France. Salvage therapy of pretreated advanced colorectal cancer (ACRC) with biweekly cetuximab (CTX), oxaliplatin (OX) and capecitabine (CAP). Preliminary results. Tzovaras A, Karagiannis A, Ntokou A,Doufexis D, Margari C,Barla G, Tsoukalas G, Stavrinidis E, Ardavanis A. Annals of oncology: Supplement 6: 12 World congress on Gastrointestinal cancer 30 June-03 July 2010, Barcelona, Spain. 2nd line salvage therapy of heavily pretreated advanced breast cancer with bevacizumab and paclitaxel every two weeks. A case series study. Ardavanis A., Doufexis D., Kountourakis P., Malliou S., Karagiannis A., Kardara E., Sykoutri D., Rigatos G. 9th International Conference on Angiogenesis, Patras, Greece 2008. Bevacizumab-based therapy leading to regression of breast cancer metastatic to CNS. Case report. Kardara E, Doufexis D, Malliou S, Kountourakis P, Karagiannis A, Nikaki A, Ardavanis A, Rigatos G. 9th International Conference on Angiogenesis, Patras, Greece 2008. PRESENTATIONS IN NATIONAL CONGRESSES: ‘’Salvage therapy of pretreated advanced breast cancer with Bevacizumab (BEV) and Paclitaxel (PAC) every two (2) weeks’’. 16th Pan-Hellenic Congress of Clinical Oncology, 22-25/4/2010. Margari C.,Doufexis D.,Tzovaras A., Kountourakis P.,Karagiannis A.,Ntokou A., Ardavanis A. 1st Department of Medical Oncology, St Savvas Anticancer hospital. ‘’Bevacizumab (BEV) and Paclitaxel (PAC) every two weeks as first line therapy in locally advanced or metastatic breast cancer’’. 16th Pan-Hellenic Congress of Clinical Oncology, 22 - 25/4/2010. Doufexis D., Margari C., Kountourakis P., Tzovaras A., Karagiannis A., ,Ntokou A., Ardavanis A. 1st Department of Medical Oncology, St Savvas Anticancer hospital. ‘’Transfer or complete avoidance of radiation for the breast cancer metastasis in CNS after BEVACIZUMAB- based chemotherapy’’. 16th Pan-Hellenic Congress of Clinical Oncology, 22-25/4/2010. Kardara E., Doufexis D., Kountourakis P., Ntokou A., Karagiannis A., Nikaki A., Margari C., Tzovaras A., Ardavanis A. 1st Department of Medical Oncology, St Savvas Anticancer hospital. ‘’Panitumumab – based chemotherapy in patients with multitreated metastatic colorectal cancer’’. 16th Pan-Hellenic Congress of Clinical Oncology, 22 - 25/4/2010. Tzovaras A., Karagiannis A., Margari C., Mparla G., Ardavanis A.. 1st Department of Medical Oncology, St Savvas Anticancer hospital. ‘’Salvage treatment of pretreated advanced colorectal cancer with Cetuximab (CTX), Οxaliplatin (OX) and Capecitabine (CAP) every two weeks’’. Tzovaras A., Karagiannis A., Margari C., Doufexis D., Ntokou A., Mparla G., Tsoukalas G., Florou K., Stavrinidis I., Ardavanis A.. 1st Department of Medical Oncology, St Savvas Anticancer hospital. ‘’The significance of the alertness of the physician resulting from a fortuitous discovery and the consequent investigation adventure’’. E. Kardara, Doufexis D, S. Malliou, P. Kountourakis, Karagiannis A, A Tzovaras, A.Nikaki, D. Sykoutri, K.Rouggas, Ardavanis A, G. Rigatos. 1st Department of Medical Oncology, St Savvas Anticancer hospital. 12th Pan-Hellenic congress of Hellenic society of psychosocial oncology. 17-19 October 2008. 12th Pan-Hellenic congress of Hellenic society of psychosocial oncology. 17-19 October 2008. Lecture on: «Communication problems between patient and medical oncologist». Oral presentation. Karagiannis A. 12th Pan-Hellenic congress of Hellenic society of psychosocial oncology. 17-19 October 2008. Chairperson. Commentary on free communications. Oral presentation. Karagiannis A. 12th Pan-Hellenic congress of Hellenic society of psychosocial oncology. 17-19 October 2008. Round table discussion, Speaker on: «Educational reflections and practices in oncology. Contribution of young oncologists». Oral presentation. Karagiannis A. 8th meeting “Physiotherapy and Oncology - Cancer Rehabilitation”, November 8, 2008. Lecture on: «Groups of cancer patients and aims of Rehabilitation». Oral presentation. Karagiannis A. 9thPanhellenic Congress of Tumor Markers and targeted therapy. 29 November-1 December 2012. AWARD : 2nd Best Poster for : “Study of the Effect of chemotherapeutical drugs on kallikrein 6 & 7 gene expression (KLK6 & KLK7) on MCF-7 breast cancer cells”. Karagiannis A., Devetzi M., Zoma M., Talieri M., Ardavanis A.
Hits: 214